Following the SEC's suspension of the Big Four's Chinese affiliates, Chinese companies have few options, and looking to Hong Kong for help is not one of them. The answer lies in diplomacy
Following the SEC's suspension of the Big Four's Chinese affiliates, Chinese companies have few options, and looking to Hong Kong for help is not one of them. The answer lies in diplomacy
China has been gradually opening up to wholly foreign-owned medical institutions, but a lack of policies has made it impossible for foreign investors to tap this market. Finally, a framework is in place in Shanghai's Free Trade Zone
Shanghui's $7.1 billion acquisition of Smithfield was closely scrutinised. Its success should lead to more US investment from Chinese companies and shows how to interact with CFIUS during acquisitions